2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrants
2.2.2. Threat of Substitute Products
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Threat of Competitive Rivalry
2.3. Industry Components
2.4. Legal Policy and Regulatory Framework
2.5. Impact of Covid-19 on Veterinary Medicines Market
2.6. Market Attractiveness Index
2.7. Key Insight
2.8. Market Drivers
2.8.1. Rise in Livestock Production
2.8.2. Surge in Various Medical Conditions in Animals
2.8.3. Increasing Ownership of Pets
2.9. Market Restraints
2.9.1. Adverse Effects of Post-Vaccination
2.9.2. Lack of Adequate Number of Veterinarians
2.10. Market Opportunities
2.10.1. Growing Animal Healthcare Expenditure
2.10.2. Increasing Demand for Veterinary Specialization
2.11. Market Challenges
2.11.1. Stringent Regulations
2.11.2. High Cost of Animal Vaccines
3. Middle East and Africa Veterinary Medicines Market Outlook -By Animal Type
3.1. Companion Animals
3.2. Livestock Animals
4. Middle East and Africa Veterinary Medicines Market Outlook - by Distribution Channel
4.1. Retail Veterinary Pharmacies
4.2. Veterinary Hospital Pharmacies
5. Middle East and Africa Veterinary Medicines Market Outlook - by Route of Administration
5.1. Parenteral Route
5.2. Oral Route
5.3. Topical Route
6. Middle East and Africa Veterinary Medicines Market Outlook - by Product
6.1. Drugs
6.1.1. Anti-Infective
6.1.2. Anti-Inflammatory
6.1.3. Parasiticide
6.2. Vaccines
6.2.1. Inactivated Vaccines
6.2.2. Attenuated Vaccines
6.2.3. Recombinant Vaccines
6.3. Medicated Feed Additives
6.3.1. Antibiotics
6.3.2. Amino Acids
7. Geographical Analysis - Middle East and Africa
7.1. Country Analysis
7.1.1. Saudi Arabia
7.1.2. United Arab Emirates
7.1.3. Turkey
7.1.4. South Africa
7.1.5. Rest of Middle East & Africa
8. Company Profiles
8.1. Evonik Industries AG (Rag Stiftung)
8.2. Indian Immunologicals Limited
8.3. Boehringer Ingelheim Animal Health GmbH
8.4. Merck & Co
8.5. Zoetis
8.6. Biogenesis Bago Sa
8.7. Vetoquinol (Soparfin Sca)
8.8. Archer Daniels Midland
8.9. Ceva Sante Animale
8.10. Virbac Sa
8.11. Dechra Pharmaceuticals plc
8.12. Neogen Corporation
8.13. Elanco
8.14. Hester Biosciences Limited
8.15. Kindred Biosciences
9. Research Methodology & Scope
9.1. Research Scope & Deliverables
9.1.1. Objectives of Study
9.1.2. Scope of Study
9.2. Sources of Data
9.2.1. Primary Data Sources
9.2.2. Secondary Data Sources
9.3. Research Methodology
9.3.1. Evaluation of Proposed Market
9.3.2. Identification of Data Sources
9.3.3. Assessment of Market Determinants
9.3.4. Data Collection
9.3.5. Data Validation & Analysis
List of Tables
Table 1: Middle East and Africa Veterinary Medicines Market, by Country, 2019-2028 (In $ Million)
Table 2: Middle East and Africa Veterinary Medicines, by Animal Type, 2019-2028 (In $ Million)
Table 3: Middle East and Africa Veterinary Medicines, by Distribution Channel, 2019-2028 (In $ Million)
Table 4: Middle East and Africa Veterinary Medicines, by Route of Administration, 2019-2028 (In $ Million)
Table 5: Middle East and Africa Veterinary Medicines, by Product, 2019-2028 (In $ Million)
Table 6: Middle East and Africa Drugs Market, by Type, 2019-2028 (In $ Million)
Table 7: Middle East and Africa Vaccines Market, by Type, 2019-2028 (In $ Million)
Table 8: Middle East and Africa Medicated Feed Additives Market, by Type, 2019-2028 (In $ Million)
Table 9: Middle East and Africa Veterinary Medicines Market, by Country, 2019-2028 (In $ Million)
List of Figures
Figure 1: Middle East and Africa Veterinary Medicines Market 2019-2028 (In $ Million)
Figure 2: Middle East and Africa Veterinary Medicines Market, by Companion Animals, 2019-2028 (In $ Million)
Figure 3: Middle East and Africa Veterinary Medicines Market, by Livestock Animals, 2019-2028 (In $ Million)
Figure 4: Middle East and Africa Veterinary Medicines Market, by Retail Veterinary Pharmacies, 2019-2028 (In $ Million)
Figure 5: Middle East and Africa Veterinary Medicines Market, by Veterinary Hospital Pharmacies, 2019-2028 (In $ Million)
Figure 6: Middle East and Africa Veterinary Medicines Market, by Parenteral Route, 2019-2028 (In $ Million)
Figure 7: Middle East and Africa Veterinary Medicines Market, by Oral Route, 2019-2028 (In $ Million)
Figure 8: Middle East and Africa Veterinary Medicines Market, by Topical Route, 2019-2028 (In $ Million)
Figure 9: Middle East and Africa Veterinary Medicines Market, by Drugs, 2019-2028 (In $ Million)
Figure 10: Middle East and Africa Drugs Market, by Anti-Infective, 2019-2028 (In $ Million)
Figure 11: Middle East and Africa Drugs Market, by Anti-Inflammatory, 2019-2028 (In $ Million)
Figure 12: Middle East and Africa Drugs Market, by Parasiticide, 2019-2028 (In $ Million)
Figure 13: Middle East and Africa Veterinary Medicines Market, by Vaccines, 2019-2028 (In $ Million)
Figure 14: Middle East and Africa Vaccines Market, by Inactivated Vaccines, 2019-2028 (In $ Million)
Figure 15: Middle East and Africa Vaccines Market, by Attenuated Vaccines, 2019-2028 (In $ Million)
Figure 16: Middle East and Africa Vaccines Market, by Recombinant Vaccines, 2019-2028 (In $ Million)
Figure 17: Middle East and Africa Veterinary Medicines Market, by Medicated Feed Additives, 2019-2028 (In $ Million)
Figure 18: Middle East and Africa Medicated Feed Additives Market, by Antibiotics, 2019-2028 (In $ Million)
Figure 19: Middle East and Africa Medicated Feed Additives Market, by Amino Acids, 2019-2028 (In $ Million)
Figure 20: Saudi Arabia Veterinary Medicines Market 2019-2028 (In $ Million)
Figure 21: United Arab Emirates Veterinary Medicines Market 2019-2028 (In $ Million)
Figure 22: Turkey Veterinary Medicines Market 2019-2028 (In $ Million)
Figure 23: South Africa Veterinary Medicines Market 2019-2028 (In $ Million)
Figure 24: Rest of Middle East & Africa Veterinary Medicines Market 2019-2028 (In $ Million)
